Get the Stockscreener App
3.99
2.84%
0.11
After Hours:
4.03
0.04
+1.00%
Precigen Inc stock is traded at $3.99, with a volume of 4.77M.
It is up +2.84% in the last 24 hours and up +22.77% over the past month.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
See More
Previous Close:
$3.88
Open:
$3.89
24h Volume:
4.77M
Relative Volume:
0.52
Market Cap:
$1.19B
Revenue:
$6.23M
Net Income/Loss:
$-95.90M
P/E Ratio:
-10.23
EPS:
-0.39
Net Cash Flow:
$-68.47M
1W Performance:
-0.50%
1M Performance:
+22.77%
6M Performance:
+162.50%
1Y Performance:
+384.69%
1-Day Range:
$3.89
$4.13
1-Week Range:
$3.855
$4.35
52-Week Range:
$0.6513
$5.225
Precigen Inc Stock (PGEN) Company Profile
Name
Precigen Inc
Sector
Industry
Phone
301-556-9900
Address
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
3.99 | 1.37B | 6.23M | -95.90M | -68.47M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
417.00 | 107.10B | 11.70B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
644.19 | 66.00B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.56 | 55.95B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
832.35 | 51.19B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.88 | 38.98B | 447.02M | -1.18B | -906.14M | -6.1812 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-15-25 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-22-24 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Initiated | JP Morgan | Neutral |
| Nov-18-22 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-25-21 | Initiated | Stifel | Buy |
| Feb-22-21 | Initiated | Wells Fargo | Overweight |
| Feb-18-21 | Initiated | B. Riley Securities | Buy |
| May-08-20 | Initiated | H.C. Wainwright | Buy |
View All
Precigen Inc Stock (PGEN) Latest News
Will Precigen Inc. stock benefit from AI adoptionPrice Action & Verified High Yield Trade Plans - newser.com
Applying chart zones and confluence areas to Precigen Inc.Product Launch & Stepwise Trade Signal Implementation - newser.com
Can you recover from losses in Precigen Inc.Portfolio Profit Report & Fast Gain Swing Alerts - newser.com
What’s the recovery path for long term holders of Precigen Inc.July 2025 Trends & AI Driven Price Forecasts - newser.com
What technical models suggest about Precigen Inc.’s comebackGold Moves & Risk Controlled Stock Alerts - newser.com
Is Precigen Inc. stock in correction or buying zoneJuly 2025 Setups & Stepwise Trade Signal Implementation - newser.com
Can technical indicators confirm Precigen Inc.’s reversalVolume Spike & Real-Time Volume Analysis Alerts - newser.com
Can Precigen Inc. stock outperform in 2025 bull marketJuly 2025 EndofMonth & Pattern Based Trade Signal System - newser.com
How Precigen Inc. stock performs in interest rate cyclesDay Trade & Safe Capital Preservation Plans - newser.com
Using data tools to time your Precigen Inc. exitTrade Performance Summary & Low Drawdown Investment Ideas - newser.com
Using R and stats models for Precigen Inc. forecasting2025 AllTime Highs & High Conviction Trade Alerts - newser.com
Will Precigen Inc. stock gain from lower inflationTrade Exit Summary & Expert Curated Trade Ideas - newser.com
Will Precigen Inc. benefit from macro trendsWeekly Trade Summary & Daily Volume Surge Signals - newser.com
Tools to assess Precigen Inc.’s risk profileJuly 2025 Trade Ideas & Fast Moving Stock Trade Plans - newser.com
Is Precigen Inc. stock near bottom after declineEarnings Overview Summary & AI Driven Stock Movement Reports - newser.com
Why Precigen Inc. stock appeals to dividend seekersJuly 2025 Price Swings & Fast Entry Momentum Trade Alerts - newser.com
How interest rate cuts could boost Precigen Inc. stockMarket Sentiment Report & Technical Entry and Exit Alerts - fcp.pa.gov.br
Strategies to average down on Precigen Inc.Earnings Trend Report & Weekly High Return Forecasts - newser.com
Chart based exit strategy for Precigen Inc.Share Buyback & Consistent Growth Equity Picks - newser.com
Can Catheter Precision Inc. stock deliver surprise earnings beat2025 Volume Leaders & Safe Entry Zone Tips - fcp.pa.gov.br
Intraday pattern recognizer results for Precigen Inc.July 2025 Weekly Recap & Weekly Momentum Picks - newser.com
How to integrate Precigen Inc. into portfolio analysis toolsFed Meeting & High Conviction Trade Alerts - newser.com
Will Precigen Inc. stock continue dividend increasesJuly 2025 Selloffs & Safe Entry Momentum Tips - newser.com
Is Precigen Inc. stock oversold or undervaluedShare Buyback & Reliable Intraday Trade Plans - newser.com
Is now a turning point for Precigen Inc.Market Trend Summary & Detailed Earnings Play Alerts - newser.com
Earnings visualization tools for Precigen Inc.Market Activity Report & Safe Entry Momentum Tips - newser.com
Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares - sharewise.com
Precigen Inc Stock (PGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.82%
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):